PMGC HOLDINGS INC. Operating Cash Flow
PMGC HOLDINGS INC. (ELAB) reported Operating Cash Flow of -$4.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.99M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.98M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.75M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.49M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$5.93M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2024 was -$5.49M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$4.56M.
- PMGC HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2022 was -$1.59M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.97M 10-Q · filed 2026-08-14 | -$6.72M derived: sum of 3 quarters · filed 2026-08-14 | -$8.21M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$2.98M 10-Q · filed 2026-05-15 | -$4.73M derived: sum of 2 quarters · filed 2026-05-15 | -$6.22M derived: sum of 3 quarters · filed 2026-05-15 | -$7.57M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$3.24M derived: sum of 2 quarters · filed 2026-03-30 | -$4.59M derived: sum of 3 quarters · filed 2026-08-14 | -$5.93M 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.84M derived: sum of 2 quarters · filed 2026-08-14 | -$4.18M 10-Q · filed 2025-11-14 | -$6.18M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.69M 10-Q · filed 2026-08-14 | -$4.69M derived: sum of 3 quarters · filed 2026-08-14 | -$5.08M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$1.35M 10-Q · filed 2026-05-15 | -$3.35M derived: sum of 2 quarters · filed 2026-05-15 | -$3.73M derived: sum of 3 quarters · filed 2026-05-15 | -$4.51M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.38M derived: sum of 2 quarters · filed 2026-03-30 | -$3.16M derived: sum of 3 quarters · filed 2026-03-30 | -$5.49M 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$381.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.16M derived: sum of 2 quarters · filed 2025-11-14 | -$3.49M 10-Q · filed 2025-11-14 | -$5.87M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$780.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.10M 10-Q · filed 2025-08-13 | -$5.49M derived: sum of 3 quarters · filed 2025-08-13 | -$6.01M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$2.32M 10-Q · filed 2025-05-14 | -$4.71M derived: sum of 2 quarters · filed 2025-05-14 | -$5.23M derived: sum of 3 quarters · filed 2025-05-14 | -$6.00M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$2.90M derived: sum of 2 quarters · filed 2025-03-28 | -$3.67M derived: sum of 3 quarters · filed 2025-03-28 | -$4.56M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$514.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.28M derived: sum of 2 quarters · filed 2024-11-14 | -$2.17M 10-Q · filed 2024-11-14 | -$2.17B 10-Q · filed 2023-12-11 | $1.08B derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$768.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.65M 10-Q · filed 2024-08-14 | $1.08B derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$885.51K 10-Q · filed 2024-05-15 | $1.08B derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $1.08B derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$1.59M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$1.08B 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |